Mark Lappe, Director, 10% Owner at REPROS THERAPEUTICS INC. (RPRX), bought 1,846,154 shares at $6.50 ($12.0M) on 2008-10-02, disclosed to the SEC on 2008-10-06.
Open-market purchase of $12.0M RPRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| INBX | BUY | 2024-09-10 | $671K | — | Filing → |
| INBX | BUY | 2024-09-03 | $913K | — | Filing → |
| INBX | BUY | 2024-08-22 | $1.0M | — | Filing → |